News and Media

May 29, 2020

Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial

Georgetown University Medical Center
December 16, 2019

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease - Audio

Jama Network
October 22, 2019

Novel agent flips on garbage disposal in neurons, eliminating toxic brain proteins in mice

Science Daily
October 8, 2019

Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia

Georgetown University
June 4, 2019

Could a Pfizer Cancer Drug be a Treatment for a Form of Dementia? Georgetown University Launches Clinical Trial to Find Out

TrialSite News
March 13, 2019

Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients

MedStar Georgetown University Hospital
September 27, 2018

Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown

Georgetown University
July 16, 2017

Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models

Georgetown University
March 17, 2017

Leukemia Drug Nilotinib Can Cure Parkinson's, Alzheimer's & Dementia As Well

The Science Times
March 15, 2017

Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests

NPR
February 27, 2017

Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease

Georgetown University
January 26, 2017

Georgetown to Lead Phase 2 Study of Cancer Drug in Treating Alzheimer’s

Alzheimer's News Today
October 12, 2016

Autophagy: How “Self-Cleaning” Cells Are Key to Curing Disease

Wall Street Daily
October 10, 2016

Nobel prize - winning autophagy research laid groundwork for potential Parkinson’s treatment

The Conversation
October 4, 2016

Autophagy: Eating up Alzheimer's disease?

STAT News
October 3, 2016

Japanese scientist Yoshinori Ohsumi wins Nobel Prize in medicine for work on cellular 'recycling'

Los Angeles Times
September 29, 2016

New Clinical Trial Will Test Cancer Drug as Alzheimer’s Treatment

Alzheimer's drug discovery foundation
September 29, 2016

Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer's disease

Georgetown University
August 10, 2016

New research hints at pattern of Alzheimer's spread in the brain

The Guardian
August 1, 2016

AAIC 2016 showcases exciting Alzheimer's developments

The Pharma Letter
July 18, 2016

Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients

Parkinson's News Today
July 18, 2016

Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients

Parkinson's News Today
July 15, 2016

Leukemia drug may have benefits for Parkinson's disease

NeurologyAdvisor
July 15, 2016

Leukemia drug may have benefits for Parkinson's disease

NeurologyAdvisor
July 14, 2016

Cancer drug could improve Parkinson's symptoms

Drug Discovery & Development
July 14, 2016

Cancer drug could improve Parkinson's symptoms

Drug Discovery & Development
July 13, 2016

Collaboration to explore nilotinib as a potential treatment for Parkinson’s

European Pharmaceutical Review
July 13, 2016

Novartis cancer drug to be tested for Parkinson’s disease

FierceBiotech
July 13, 2016

Collaboration to explore nilotinib as a potential treatment for Parkinson’s

European Pharmaceutical Review
July 13, 2016

Novartis cancer drug to be tested for Parkinson’s disease

FierceBiotech
Copyright 2020 - KeifeRx